Companies / Dare Bioscience, Inc.

Dare Bioscience, Inc.

Nasdaq: DARECIK 1401914SAN DIEGO, CA

Financials · FY2025

Revenue$1.03M
Net income$-13.40M
Total debt
Cash$12.62M
Diluted EPS$-1.20
Shares outstanding15.0M

Ownership

15.0M shares outstanding · as of May 13, 2026
7.3%Institutions
Ownership
Institutions7.26%1,088,074
Public float92.74%13,891,428

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Haring-Layton MarDeeChief Accounting Officer
Johnson Sabrina MartucciChef Executive Officer · Director

Institutional holders 28

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 11, 2026Steele Robin Joan
Director
GrantStock Option (right to buy)+10K
10,000
0.07% of shares
low
Jun 11, 2026Rastetter William H
Director
GrantStock Option (right to buy)+10K
10,000
0.07% of shares
low
Jan 30, 2026Haring-Layton MarDee
Executive
GrantEmployee Stock Option (right to buy)+49K
49,000
0.33% of shares
low
Feb 18, 2026Johnson Sabrina Martucci
Executive
GrantCommon Stock Warrant (right to buy)+22K
21,600
0.14% of shares
low
Feb 18, 2026Johnson Sabrina Martucci
Executive
GrantSeries A Convertible Preferred Stock+11K
10,800
0.07% of shares
low
Jan 30, 2026Johnson Sabrina Martucci
Executive
GrantEmployee Stock Option (right to buy)+172K
172,000
1.15% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
DARECommon StockEquity23666P200BBG001J2P362